내시경 검사용 AI 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global AI In Endoscopy Market size is anticipated to grow from USD 19.17 Billion in 2024 to USD 235.12 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 32.12% during the forecast period of 2026 to 2033.

The AI in endoscopy market is experiencing a paradigm shift, fueled by the integration of artificial intelligence technologies that enhance diagnostic accuracy and procedural efficiency. As healthcare systems worldwide strive to improve patient outcomes while managing costs, AI-driven solutions are emerging as indispensable tools in the realm of endoscopic procedures. The ability of AI algorithms to analyze vast amounts of imaging data in real-time allows for the early detection of abnormalities, significantly improving the chances of successful interventions. This trend is particularly relevant in the context of rising incidences of gastrointestinal disorders, where timely diagnosis is critical.

The continuous evolution of machine learning and deep learning techniques is propelling advancements in AI applications for endoscopy. These technologies enable the development of sophisticated image recognition systems that can assist clinicians in identifying polyps, tumors, and other pathological conditions with unprecedented precision. Furthermore, the integration of AI with augmented reality and robotic-assisted endoscopy is set to revolutionize procedural approaches, enhancing the capabilities of healthcare professionals and improving patient experiences. As the technology matures, the potential for AI to facilitate personalized treatment plans based on individual patient data is becoming increasingly viable, paving the way for more targeted and effective interventions.

Moreover, the regulatory landscape is evolving to accommodate the rapid advancements in AI technologies within the medical field. As healthcare providers seek to adopt AI-driven endoscopic solutions, collaboration between technology developers and regulatory bodies will be essential to ensure safety and efficacy. The growing body of clinical evidence supporting the benefits of AI in endoscopy is likely to accelerate adoption rates, as healthcare institutions recognize the value of integrating these technologies into their practices. In conclusion, the AI in endoscopy market is set for remarkable growth, driven by technological innovation, improved patient outcomes, and a commitment to advancing healthcare delivery.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

• Flexible Endoscopes
• Rigid Endoscopes

By Application

• Gastrointestinal Endoscopy
• Urological Endoscopy
• Respiratory Endoscopy
• Colonoscopy

By Techniques Autofluorescence Endoscopy

• Confocal Endoscopy
• Endoscopic Ultrasound
• Capsule Endoscopy

By Imaging Modalities

• White-Light Endoscopy
• Fluorescence Endoscopy
• Narrow-Band Imaging
• High-Definition Endoscopy
• COMPANIES PROFILED
• Richard Wolf
• Stryker
• PENTAX Medical
• Fujifilm Holdings
• Olympus Corporation
• Ambu A/S
• Medtronic
• Intuitive Surgical
• Hoya Corporation
• Cook Medical
• Karl Storz
• Conmed
• Smith & Nephew
• Erbe Elektromedizin
• Boston Scientific.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AI IN ENDOSCOPY INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Techniques
  • 3.7.4 Market Attractiveness Analysis By Imaging Modalities
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AI IN ENDOSCOPY MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Flexible Endoscopes Historic and Forecast Sales By Regions
• 5.4. Rigid Endoscopes Historic and Forecast Sales By Regions

6. GLOBAL AI IN ENDOSCOPY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Gastrointestinal Endoscopy Historic and Forecast Sales By Regions
• 6.4. Urological Endoscopy Historic and Forecast Sales By Regions
• 6.5. Respiratory Endoscopy Historic and Forecast Sales By Regions
• 6.6. Colonoscopy Historic and Forecast Sales By Regions

7. GLOBAL AI IN ENDOSCOPY MARKET ANALYSIS BY TECHNIQUES

• 7.1. Overview By Techniques
• 7.2. Historical and Forecast Data Analysis By Techniques
• 7.3. Autofluorescence Endoscopy Historic and Forecast Sales By Regions
• 7.4. Confocal Endoscopy Historic and Forecast Sales By Regions
• 7.5. Endoscopic Ultrasound Historic and Forecast Sales By Regions
• 7.6. Capsule Endoscopy Historic and Forecast Sales By Regions

8. GLOBAL AI IN ENDOSCOPY MARKET ANALYSIS BY IMAGING MODALITIES

• 8.1. Overview By Imaging Modalities
• 8.2. Historical and Forecast Data Analysis By Imaging Modalities
• 8.3. White-Light Endoscopy Historic and Forecast Sales By Regions
• 8.4. Fluorescence Endoscopy Historic and Forecast Sales By Regions
• 8.5. Narrow-Band Imaging Historic and Forecast Sales By Regions
• 8.6. High-Definition Endoscopy Historic and Forecast Sales By Regions

9. GLOBAL AI IN ENDOSCOPY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AI IN ENDOSCOPY COMPANIES

• 10.1. AI In Endoscopy Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF AI IN ENDOSCOPY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Richard Wolf
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Stryker
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. PENTAX Medical
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Fujifilm Holdings
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Olympus Corporation
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Ambu A/S
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Medtronic
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Intuitive Surgical
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Hoya Corporation
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Cook Medical
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Karl Storz
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Conmed
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Smith & Nephew
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Erbe Elektromedizin
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Boston Scientific
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies